Latest Insider Transactions at Azenta, Inc. (AZTA)
This section provides a real-time view of insider transactions for Azenta, Inc. (AZTA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Azenta, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Azenta, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 11
2022
|
Robyn C Davis |
BUY
Grant, award, or other acquisition
|
Direct |
1,922
+7.56%
|
-
|
|
Feb 11
2022
|
Joseph R Martin Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,808
+3.1%
|
-
|
|
Jan 31
2022
|
Kimberly Crowley SVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
110
+2.05%
|
$7,590
$69.29 P/Share
|
|
Jan 31
2022
|
Lindon G Robertson EVP & Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
189
+0.2%
|
$13,041
$69.29 P/Share
|
|
Jan 31
2022
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
285
+1.21%
|
$19,665
$69.29 P/Share
|
|
Jan 06
2022
|
Joseph R Martin Director |
SELL
Bona fide gift
|
Direct |
1,000
-1.16%
|
-
|
|
Jan 04
2022
|
Linda De Jesus Chief Commercial Officer, LS |
SELL
Open market or private sale
|
Direct |
191
-6.56%
|
$19,482
$102.59 P/Share
|
|
Nov 19
2021
|
David Jarzynka President, Semi Solutions |
SELL
Open market or private sale
|
Direct |
10,216
-18.07%
|
$1,225,920
$120.29 P/Share
|
|
Nov 18
2021
|
David C Gray Chief Strategy & New Business |
SELL
Open market or private sale
|
Direct |
4,049
-4.59%
|
$477,782
$118.48 P/Share
|
|
Nov 18
2021
|
Robin Vacha SVP, GM Life Science Products |
SELL
Open market or private sale
|
Direct |
6,490
-22.06%
|
$772,310
$119.03 P/Share
|
|
Nov 17
2021
|
David C Gray Chief Strategy & New Business |
SELL
Open market or private sale
|
Direct |
7,402
-3.92%
|
$880,838
$119.27 P/Share
|
|
Nov 17
2021
|
David Jarzynka President, Semi Solutions |
SELL
Open market or private sale
|
Direct |
13,100
-9.7%
|
$1,558,900
$119.27 P/Share
|
|
Nov 17
2021
|
David Pietrantoni Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
4,830
-7.68%
|
$574,770
$119.27 P/Share
|
|
Nov 17
2021
|
Lindon G Robertson EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
18,331
-8.27%
|
$2,181,389
$119.27 P/Share
|
|
Nov 17
2021
|
Stephen S Schwartz CEO |
SELL
Open market or private sale
|
Direct |
41,351
-4.99%
|
$4,920,769
$119.27 P/Share
|
|
Nov 17
2021
|
Robin Vacha SVP, GM Life Science Products |
SELL
Open market or private sale
|
Direct |
8,878
-12.07%
|
$1,056,482
$119.27 P/Share
|
|
Nov 17
2021
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Open market or private sale
|
Direct |
8,694
-4.47%
|
$1,034,586
$119.27 P/Share
|
|
Nov 15
2021
|
Kimberly Crowley SVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,092
+17.48%
|
-
|
|
Nov 15
2021
|
David C Gray Chief Strategy & New Business |
BUY
Grant, award, or other acquisition
|
Direct |
18,292
+8.33%
|
-
|
|
Nov 15
2021
|
David Jarzynka President, Semi Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
25,710
+26.97%
|
-
|
|
Nov 15
2021
|
Jason Joseph SVP, General Counsel, Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
20,407
+11.53%
|
-
|
|
Nov 15
2021
|
David Pietrantoni Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,642
+23.04%
|
-
|
|
Nov 15
2021
|
Lindon G Robertson EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,585
+12.87%
|
-
|
|
Nov 15
2021
|
Stephen S Schwartz CEO |
BUY
Grant, award, or other acquisition
|
Direct |
87,994
+9.03%
|
-
|
|
Nov 15
2021
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
19,102
+18.5%
|
-
|
|
Nov 12
2021
|
Michael Rosenblatt |
SELL
Open market or private sale
|
Direct |
2,831
-35.92%
|
$322,734
$114.13 P/Share
|
|
Nov 05
2021
|
Frank Casal |
BUY
Grant, award, or other acquisition
|
Direct |
263
+50.0%
|
-
|
|
Sep 27
2021
|
William T. Montone SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
4,140
-4.31%
|
$455,400
$110.0 P/Share
|
|
Sep 22
2021
|
David Pietrantoni Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,500
-9.97%
|
$262,500
$105.0 P/Share
|
|
Sep 20
2021
|
William T. Montone SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
4,140
-4.13%
|
$430,560
$104.0 P/Share
|
|
Sep 20
2021
|
David Pietrantoni Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
12,500
-45.35%
|
$1,250,000
$100.0 P/Share
|
|
Sep 07
2021
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Open market or private sale
|
Direct |
1,071
-1.34%
|
$96,390
$90.0 P/Share
|
|
Jul 31
2021
|
Linda De Jesus Chief Commercial Officer, LS |
BUY
Grant, award, or other acquisition
|
Direct |
281
+8.8%
|
-
|
|
Jul 31
2021
|
Lindon G Robertson EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
129
+0.11%
|
-
|
|
Jul 31
2021
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
221
+0.57%
|
-
|
|
Jul 21
2021
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Open market or private sale
|
Direct |
1,071
-1.32%
|
$96,390
$90.0 P/Share
|
|
Jun 28
2021
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Open market or private sale
|
Direct |
1,071
-1.3%
|
$104,958
$98.0 P/Share
|
|
Jun 28
2021
|
William T. Montone SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
4,139
-3.97%
|
$405,622
$98.0 P/Share
|
|
Jun 24
2021
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Open market or private sale
|
Direct |
1,071
-1.29%
|
$101,745
$95.0 P/Share
|
|
Jun 24
2021
|
David Pietrantoni Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,000
-6.77%
|
$190,000
$95.0 P/Share
|
|
Jun 24
2021
|
Stephen S Schwartz CEO |
SELL
Open market or private sale
|
Direct |
19,500
-5.54%
|
$1,852,500
$95.0 P/Share
|
|
Jun 21
2021
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Open market or private sale
|
Direct |
1,071
-1.27%
|
$97,461
$91.78 P/Share
|
|
Jun 18
2021
|
Stephen S Schwartz CEO |
SELL
Open market or private sale
|
Direct |
25,500
-3.38%
|
$2,371,500
$93.48 P/Share
|
|
May 27
2021
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Bona fide gift
|
Direct |
1,632
-1.9%
|
-
|
|
May 13
2021
|
Michael Rosenblatt |
SELL
Open market or private sale
|
Direct |
1,760
-18.25%
|
$158,400
$90.0 P/Share
|
|
Feb 05
2021
|
Joseph R Martin Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,262
+2.57%
|
-
|
|
Feb 05
2021
|
Ellen M Zane Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,760
+3.14%
|
-
|
|
Feb 05
2021
|
Robyn C Davis |
BUY
Grant, award, or other acquisition
|
Direct |
1,760
+7.54%
|
-
|
|
Feb 05
2021
|
Erica Mc Laughlin |
BUY
Grant, award, or other acquisition
|
Direct |
1,760
+26.72%
|
-
|
|
Feb 05
2021
|
Krishna G. Palepu Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,760
+1.73%
|
-
|